Literature DB >> 12525276

Organ preservation strategies in the treatment of laryngeal cancer.

George E Laramore1, Marc D Coltrera.   

Abstract

For most patients, a total laryngectomy should not be used as the initial treatment for any stage laryngeal tumor. The goal in treating a patient with laryngeal cancer must be not only to cure but also to provide the best functional outcome for the patient. In the United States, the treatment of laryngeal cancer has moved from radical surgery toward a more conservative approach involving definitive radiotherapy and chemotherapy, with extirpative surgery held in reserve for salvage. In Europe, there has been increasing reliance on limited endoscopic cordectomy procedures for early tumors and the use of function-preserving surgical approaches for more advanced lesions. Careful monitoring of the conservatively treated patient is mandatory to allow for early salvage of failures to the original therapy. Because of the high costs of hospitalization, the direct medical costs attributable to conservative approaches are equal to or less than the costs for more radical surgical resections. Even if survivals are only equivalent, organ preservation approaches should be the treatment of choice for most patients.

Entities:  

Mesh:

Year:  2003        PMID: 12525276     DOI: 10.1007/s11864-003-0028-5

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  33 in total

1.  Commentary: phase III trial to preserve the larynx: induction chemotherapy and radiotherapy versus concurrent chemotherapy and radiotherapy versus radiotherapy--intergroup trial R91-11.

Authors:  G T Wolf
Journal:  J Clin Oncol       Date:  2001-09-15       Impact factor: 44.544

2.  Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer.

Authors:  Gregory T Wolf; Susan Gross Fisher; Waun Ki Hong; Robert Hillman; Monica Spaulding; George E Laramore; James W Endicott; Kenneth McClatchey; William G Henderson
Journal:  N Engl J Med       Date:  1991-06-13       Impact factor: 91.245

3.  Early-stage glottic cancer: importance of dose fractionation in radiation therapy.

Authors:  R Y Kim; M E Marks; M M Salter
Journal:  Radiology       Date:  1992-01       Impact factor: 11.105

4.  Cricohyoidoepiglottopexy for glottic carcinoma with fixation or impaired motion of the true vocal cord: 5-year oncologic results with 112 patients.

Authors:  D Chevalier; O Laccourreye; D Brasnu; H Laccourreye; J J Piquet
Journal:  Ann Otol Rhinol Laryngol       Date:  1997-05       Impact factor: 1.547

Review 5.  Functional outcomes following treatment for advanced laryngeal cancer. Part I--Voice preservation in advanced laryngeal cancer. Part II--Laryngectomy rehabilitation: the state of the art in the VA System. Research Speech-Language Pathologists. Department of Veterans Affairs Laryngeal Cancer Study Group.

Authors:  R E Hillman; M J Walsh; G T Wolf; S G Fisher; W K Hong
Journal:  Ann Otol Rhinol Laryngol Suppl       Date:  1998-05

6.  Radiation treatment of glottic squamous cell carcinoma, stage I and II: analysis of factors affecting prognosis.

Authors:  G Franchin; E Minatel; C Gobitti; R Talamini; G Sartor; G Caruso; G Grando; D Politi; M Gigante; G Toffoli; M G Trovò; L Barzan
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-02-01       Impact factor: 7.038

Review 7.  T3N0M0 glottic cancer: are more treatment modalities necessarily better?

Authors:  G E Laramore
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-01-15       Impact factor: 7.038

Review 8.  Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience.

Authors:  J S Cooper; T F Pajak; P Rubin; L Tupchong; L W Brady; S A Leibel; G E Laramore; V A Marcial; L W Davis; J D Cox
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-09       Impact factor: 7.038

9.  Thiol WR-1065 and disulphide WR-33278, two metabolites of the drug ethyol (WR-2721), protect DNA against fast neutron-induced strand breakage.

Authors:  C Savoye; C Swenberg; S Hugot; D Sy; R Sabattier; M Charlier; M Spotheim-Maurizot
Journal:  Int J Radiat Biol       Date:  1997-02       Impact factor: 2.694

10.  Environmental factors in cancer of the larynx: a second look.

Authors:  E L Wynder; L S Covey; K Mabuchi; M Mushinski
Journal:  Cancer       Date:  1976-10       Impact factor: 6.860

View more
  1 in total

1.  A rich lymphatic network exists in the inferior surface of the vocal cord.

Authors:  Y-H Liu; S-C Xu; L-L Tu; K-L Zhang; D-H Lu; M Zhang
Journal:  Surg Radiol Anat       Date:  2006-02-15       Impact factor: 1.246

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.